Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Endonovo Therapeutics (ENDV) Treasury Shares (2019)

Endonovo Therapeutics has reported Treasury Shares over the past 2 years, most recently at $17900.0 for Q4 2019.

  • Quarterly results put Treasury Shares at $17900.0 for Q4 2019, changed N/A from a year ago — trailing twelve months through Dec 2019 was $17900.0 (changed N/A YoY), and the annual figure for FY2019 was $17900.0, changed.
  • Treasury Shares for Q4 2019 was $17900.0 at Endonovo Therapeutics, down from $1.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for ENDV hit a ceiling of $2.0 million in Q1 2019 and a floor of $4400.0 in Q2 2019.